Pharma & Healthcare
Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1442
- Pages: 95
- Figures: 113
- Views: 14
A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111，and other SPECT isotopes.
The global SPECT Radiopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of SPECT Radiopharmaceuticals include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging and Jubilant Life Sciences, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for SPECT Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of SPECT Radiopharmaceuticals, also provides the sales of main regions and countries. Highlights of the upcoming market potential for SPECT Radiopharmaceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the SPECT Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global SPECT Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for SPECT Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Segment by Application
Oncology
Cardiology
Thyroid
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of SPECT Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of SPECT Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SPECT Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global SPECT Radiopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for SPECT Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of SPECT Radiopharmaceuticals include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging and Jubilant Life Sciences, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for SPECT Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of SPECT Radiopharmaceuticals, also provides the sales of main regions and countries. Highlights of the upcoming market potential for SPECT Radiopharmaceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the SPECT Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global SPECT Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for SPECT Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Segment by Application
Oncology
Cardiology
Thyroid
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of SPECT Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of SPECT Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SPECT Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 SPECT Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Technetium-99
1.2.3 Thallium-201
1.2.4 Gallium-67
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Other
1.3 Market by Application
1.3.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Thyroid
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts 2019-2030
2.2 Global SPECT Radiopharmaceuticals Revenue by Region
2.2.1 Global SPECT Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global SPECT Radiopharmaceuticals Revenue by Region (2019-2024)
2.2.3 Global SPECT Radiopharmaceuticals Revenue by Region (2025-2030)
2.2.4 Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
2.3 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts 2019-2030
2.4 Global SPECT Radiopharmaceuticals Sales by Region
2.4.1 Global SPECT Radiopharmaceuticals Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global SPECT Radiopharmaceuticals Sales by Region (2019-2024)
2.4.3 Global SPECT Radiopharmaceuticals Sales by Region (2025-2030)
2.4.4 Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global SPECT Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global SPECT Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.1.2 Global SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SPECT Radiopharmaceuticals in 2023
3.2 Global SPECT Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global SPECT Radiopharmaceuticals Revenue by Manufacturers (2019-2024)
3.2.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by SPECT Radiopharmaceuticals Revenue in 2023
3.3 Global Key Players of SPECT Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global SPECT Radiopharmaceuticals Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of SPECT Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of SPECT Radiopharmaceuticals, Product Offered and Application
3.8 Global Key Manufacturers of SPECT Radiopharmaceuticals, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global SPECT Radiopharmaceuticals Sales by Type
4.1.1 Global SPECT Radiopharmaceuticals Historical Sales by Type (2019-2024)
4.1.2 Global SPECT Radiopharmaceuticals Forecasted Sales by Type (2025-2030)
4.1.3 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global SPECT Radiopharmaceuticals Revenue by Type
4.2.1 Global SPECT Radiopharmaceuticals Historical Revenue by Type (2019-2024)
4.2.2 Global SPECT Radiopharmaceuticals Forecasted Revenue by Type (2025-2030)
4.2.3 Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global SPECT Radiopharmaceuticals Price by Type
4.3.1 Global SPECT Radiopharmaceuticals Price by Type (2019-2024)
4.3.2 Global SPECT Radiopharmaceuticals Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global SPECT Radiopharmaceuticals Sales by Application
5.1.1 Global SPECT Radiopharmaceuticals Historical Sales by Application (2019-2024)
5.1.2 Global SPECT Radiopharmaceuticals Forecasted Sales by Application (2025-2030)
5.1.3 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global SPECT Radiopharmaceuticals Revenue by Application
5.2.1 Global SPECT Radiopharmaceuticals Historical Revenue by Application (2019-2024)
5.2.2 Global SPECT Radiopharmaceuticals Forecasted Revenue by Application (2025-2030)
5.2.3 Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global SPECT Radiopharmaceuticals Price by Application
5.3.1 Global SPECT Radiopharmaceuticals Price by Application (2019-2024)
5.3.2 Global SPECT Radiopharmaceuticals Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada SPECT Radiopharmaceuticals Market Size by Type
6.1.1 US & Canada SPECT Radiopharmaceuticals Sales by Type (2019-2030)
6.1.2 US & Canada SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
6.2 US & Canada SPECT Radiopharmaceuticals Market Size by Application
6.2.1 US & Canada SPECT Radiopharmaceuticals Sales by Application (2019-2030)
6.2.2 US & Canada SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
6.3 US & Canada SPECT Radiopharmaceuticals Market Size by Country
6.3.1 US & Canada SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada SPECT Radiopharmaceuticals Sales by Country (2019-2030)
6.3.3 US & Canada SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe SPECT Radiopharmaceuticals Market Size by Type
7.1.1 Europe SPECT Radiopharmaceuticals Sales by Type (2019-2030)
7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
7.2 Europe SPECT Radiopharmaceuticals Market Size by Application
7.2.1 Europe SPECT Radiopharmaceuticals Sales by Application (2019-2030)
7.2.2 Europe SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
7.3 Europe SPECT Radiopharmaceuticals Market Size by Country
7.3.1 Europe SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe SPECT Radiopharmaceuticals Sales by Country (2019-2030)
7.3.3 Europe SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China SPECT Radiopharmaceuticals Market Size
8.1.1 China SPECT Radiopharmaceuticals Sales (2019-2030)
8.1.2 China SPECT Radiopharmaceuticals Revenue (2019-2030)
8.2 China SPECT Radiopharmaceuticals Market Size by Application
8.2.1 China SPECT Radiopharmaceuticals Sales by Application (2019-2030)
8.2.2 China SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia SPECT Radiopharmaceuticals Market Size by Type
9.1.1 Asia SPECT Radiopharmaceuticals Sales by Type (2019-2030)
9.1.2 Asia SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
9.2 Asia SPECT Radiopharmaceuticals Market Size by Application
9.2.1 Asia SPECT Radiopharmaceuticals Sales by Application (2019-2030)
9.2.2 Asia SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
9.3 Asia SPECT Radiopharmaceuticals Sales by Region
9.3.1 Asia SPECT Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia SPECT Radiopharmaceuticals Revenue by Region (2019-2030)
9.3.3 Asia SPECT Radiopharmaceuticals Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Market Size by Type
10.1.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Market Size by Application
10.2.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country
10.3.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Overview
11.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GE Healthcare SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GE Healthcare Recent Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health Overview
11.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Cardinal Health SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cardinal Health Recent Developments
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Information
11.3.2 Lantheus Medical Imaging Overview
11.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lantheus Medical Imaging Recent Developments
11.4 Bracco Imaging
11.4.1 Bracco Imaging Company Information
11.4.2 Bracco Imaging Overview
11.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bracco Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bracco Imaging Recent Developments
11.5 Eczacibasi-Monrol Nuclear Products
11.5.1 Eczacibasi-Monrol Nuclear Products Company Information
11.5.2 Eczacibasi-Monrol Nuclear Products Overview
11.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments
11.6 IBA Molecular Imaging
11.6.1 IBA Molecular Imaging Company Information
11.6.2 IBA Molecular Imaging Overview
11.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IBA Molecular Imaging Recent Developments
11.7 Jubilant Life Sciences
11.7.1 Jubilant Life Sciences Company Information
11.7.2 Jubilant Life Sciences Overview
11.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jubilant Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SPECT Radiopharmaceuticals Industry Chain Analysis
12.2 SPECT Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SPECT Radiopharmaceuticals Production Mode & Process
12.4 SPECT Radiopharmaceuticals Sales and Marketing
12.4.1 SPECT Radiopharmaceuticals Sales Channels
12.4.2 SPECT Radiopharmaceuticals Distributors
12.5 SPECT Radiopharmaceuticals Customers
13 Market Dynamics
13.1 SPECT Radiopharmaceuticals Industry Trends
13.2 SPECT Radiopharmaceuticals Market Drivers
13.3 SPECT Radiopharmaceuticals Market Challenges
13.4 SPECT Radiopharmaceuticals Market Restraints
14 Key Findings in The Global SPECT Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 SPECT Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Technetium-99
1.2.3 Thallium-201
1.2.4 Gallium-67
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Other
1.3 Market by Application
1.3.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Thyroid
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts 2019-2030
2.2 Global SPECT Radiopharmaceuticals Revenue by Region
2.2.1 Global SPECT Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global SPECT Radiopharmaceuticals Revenue by Region (2019-2024)
2.2.3 Global SPECT Radiopharmaceuticals Revenue by Region (2025-2030)
2.2.4 Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
2.3 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts 2019-2030
2.4 Global SPECT Radiopharmaceuticals Sales by Region
2.4.1 Global SPECT Radiopharmaceuticals Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global SPECT Radiopharmaceuticals Sales by Region (2019-2024)
2.4.3 Global SPECT Radiopharmaceuticals Sales by Region (2025-2030)
2.4.4 Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global SPECT Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global SPECT Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.1.2 Global SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SPECT Radiopharmaceuticals in 2023
3.2 Global SPECT Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global SPECT Radiopharmaceuticals Revenue by Manufacturers (2019-2024)
3.2.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by SPECT Radiopharmaceuticals Revenue in 2023
3.3 Global Key Players of SPECT Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global SPECT Radiopharmaceuticals Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of SPECT Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of SPECT Radiopharmaceuticals, Product Offered and Application
3.8 Global Key Manufacturers of SPECT Radiopharmaceuticals, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global SPECT Radiopharmaceuticals Sales by Type
4.1.1 Global SPECT Radiopharmaceuticals Historical Sales by Type (2019-2024)
4.1.2 Global SPECT Radiopharmaceuticals Forecasted Sales by Type (2025-2030)
4.1.3 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global SPECT Radiopharmaceuticals Revenue by Type
4.2.1 Global SPECT Radiopharmaceuticals Historical Revenue by Type (2019-2024)
4.2.2 Global SPECT Radiopharmaceuticals Forecasted Revenue by Type (2025-2030)
4.2.3 Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global SPECT Radiopharmaceuticals Price by Type
4.3.1 Global SPECT Radiopharmaceuticals Price by Type (2019-2024)
4.3.2 Global SPECT Radiopharmaceuticals Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global SPECT Radiopharmaceuticals Sales by Application
5.1.1 Global SPECT Radiopharmaceuticals Historical Sales by Application (2019-2024)
5.1.2 Global SPECT Radiopharmaceuticals Forecasted Sales by Application (2025-2030)
5.1.3 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global SPECT Radiopharmaceuticals Revenue by Application
5.2.1 Global SPECT Radiopharmaceuticals Historical Revenue by Application (2019-2024)
5.2.2 Global SPECT Radiopharmaceuticals Forecasted Revenue by Application (2025-2030)
5.2.3 Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global SPECT Radiopharmaceuticals Price by Application
5.3.1 Global SPECT Radiopharmaceuticals Price by Application (2019-2024)
5.3.2 Global SPECT Radiopharmaceuticals Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada SPECT Radiopharmaceuticals Market Size by Type
6.1.1 US & Canada SPECT Radiopharmaceuticals Sales by Type (2019-2030)
6.1.2 US & Canada SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
6.2 US & Canada SPECT Radiopharmaceuticals Market Size by Application
6.2.1 US & Canada SPECT Radiopharmaceuticals Sales by Application (2019-2030)
6.2.2 US & Canada SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
6.3 US & Canada SPECT Radiopharmaceuticals Market Size by Country
6.3.1 US & Canada SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada SPECT Radiopharmaceuticals Sales by Country (2019-2030)
6.3.3 US & Canada SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe SPECT Radiopharmaceuticals Market Size by Type
7.1.1 Europe SPECT Radiopharmaceuticals Sales by Type (2019-2030)
7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
7.2 Europe SPECT Radiopharmaceuticals Market Size by Application
7.2.1 Europe SPECT Radiopharmaceuticals Sales by Application (2019-2030)
7.2.2 Europe SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
7.3 Europe SPECT Radiopharmaceuticals Market Size by Country
7.3.1 Europe SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe SPECT Radiopharmaceuticals Sales by Country (2019-2030)
7.3.3 Europe SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China SPECT Radiopharmaceuticals Market Size
8.1.1 China SPECT Radiopharmaceuticals Sales (2019-2030)
8.1.2 China SPECT Radiopharmaceuticals Revenue (2019-2030)
8.2 China SPECT Radiopharmaceuticals Market Size by Application
8.2.1 China SPECT Radiopharmaceuticals Sales by Application (2019-2030)
8.2.2 China SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia SPECT Radiopharmaceuticals Market Size by Type
9.1.1 Asia SPECT Radiopharmaceuticals Sales by Type (2019-2030)
9.1.2 Asia SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
9.2 Asia SPECT Radiopharmaceuticals Market Size by Application
9.2.1 Asia SPECT Radiopharmaceuticals Sales by Application (2019-2030)
9.2.2 Asia SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
9.3 Asia SPECT Radiopharmaceuticals Sales by Region
9.3.1 Asia SPECT Radiopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia SPECT Radiopharmaceuticals Revenue by Region (2019-2030)
9.3.3 Asia SPECT Radiopharmaceuticals Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Market Size by Type
10.1.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Market Size by Application
10.2.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country
10.3.1 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Overview
11.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GE Healthcare SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GE Healthcare Recent Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health Overview
11.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Cardinal Health SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cardinal Health Recent Developments
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Information
11.3.2 Lantheus Medical Imaging Overview
11.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lantheus Medical Imaging Recent Developments
11.4 Bracco Imaging
11.4.1 Bracco Imaging Company Information
11.4.2 Bracco Imaging Overview
11.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bracco Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bracco Imaging Recent Developments
11.5 Eczacibasi-Monrol Nuclear Products
11.5.1 Eczacibasi-Monrol Nuclear Products Company Information
11.5.2 Eczacibasi-Monrol Nuclear Products Overview
11.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments
11.6 IBA Molecular Imaging
11.6.1 IBA Molecular Imaging Company Information
11.6.2 IBA Molecular Imaging Overview
11.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IBA Molecular Imaging Recent Developments
11.7 Jubilant Life Sciences
11.7.1 Jubilant Life Sciences Company Information
11.7.2 Jubilant Life Sciences Overview
11.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jubilant Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SPECT Radiopharmaceuticals Industry Chain Analysis
12.2 SPECT Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SPECT Radiopharmaceuticals Production Mode & Process
12.4 SPECT Radiopharmaceuticals Sales and Marketing
12.4.1 SPECT Radiopharmaceuticals Sales Channels
12.4.2 SPECT Radiopharmaceuticals Distributors
12.5 SPECT Radiopharmaceuticals Customers
13 Market Dynamics
13.1 SPECT Radiopharmaceuticals Industry Trends
13.2 SPECT Radiopharmaceuticals Market Drivers
13.3 SPECT Radiopharmaceuticals Market Challenges
13.4 SPECT Radiopharmaceuticals Market Restraints
14 Key Findings in The Global SPECT Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Technetium-99
Table 3. Major Manufacturers of Thallium-201
Table 4. Major Manufacturers of Gallium-67
Table 5. Major Manufacturers of Iodine-123
Table 6. Major Manufacturers of Indium-111
Table 7. Major Manufacturers of Other
Table 8. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global SPECT Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 11. Global SPECT Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 12. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 13. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
Table 14. Global SPECT Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global SPECT Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 16. Global SPECT Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
Table 17. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 18. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2025-2030)
Table 19. Global SPECT Radiopharmaceuticals Sales by Manufacturers (2019-2024) & (K Units)
Table 20. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2019-2024)
Table 21. Global SPECT Radiopharmaceuticals Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 22. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 23. Global Key Players of SPECT Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
Table 24. SPECT Radiopharmaceuticals Price by Manufacturers 2019-2024 (USD/Unit)
Table 25. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT Radiopharmaceuticals as of 2023)
Table 27. Global Key Manufacturers of SPECT Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of SPECT Radiopharmaceuticals, Product Offered and Application
Table 29. Global Key Manufacturers of SPECT Radiopharmaceuticals, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 32. Global SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 33. Global SPECT Radiopharmaceuticals Sales Share by Type (2019-2024)
Table 34. Global SPECT Radiopharmaceuticals Sales Share by Type (2025-2030)
Table 35. Global SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global SPECT Radiopharmaceuticals Revenue Share by Type (2019-2024)
Table 38. Global SPECT Radiopharmaceuticals Revenue Share by Type (2025-2030)
Table 39. SPECT Radiopharmaceuticals Price by Type (2019-2024) & (USD/Unit)
Table 40. Global SPECT Radiopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Unit)
Table 41. Global SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 42. Global SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 43. Global SPECT Radiopharmaceuticals Sales Share by Application (2019-2024)
Table 44. Global SPECT Radiopharmaceuticals Sales Share by Application (2025-2030)
Table 45. Global SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global SPECT Radiopharmaceuticals Revenue Share by Application (2019-2024)
Table 48. Global SPECT Radiopharmaceuticals Revenue Share by Application (2025-2030)
Table 49. SPECT Radiopharmaceuticals Price by Application (2019-2024) & (USD/Unit)
Table 50. Global SPECT Radiopharmaceuticals Price Forecast by Application (2025-2030) & (USD/Unit)
Table 51. US & Canada SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 52. US & Canada SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 53. US & Canada SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 54. US & Canada SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 55. US & Canada SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 56. US & Canada SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 57. US & Canada SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 58. US & Canada SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 59. US & Canada SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. US & Canada SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 61. US & Canada SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 62. US & Canada SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 63. US & Canada SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 64. Europe SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 65. Europe SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 66. Europe SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 69. Europe SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 70. Europe SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 76. Europe SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 77. China SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 78. China SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 79. China SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 80. China SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 81. China SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 82. China SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 83. China SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 84. China SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 85. Asia SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 86. Asia SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 87. Asia SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 88. Asia SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 89. Asia SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 90. Asia SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 91. Asia SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 93. Asia SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 94. Asia SPECT Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 95. Asia SPECT Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 96. Asia SPECT Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 97. Asia SPECT Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 103. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 107. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 111. GE Healthcare Company Information
Table 112. GE Healthcare Description and Major Businesses
Table 113. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GE Healthcare SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. GE Healthcare Recent Developments
Table 116. Cardinal Health Company Information
Table 117. Cardinal Health Description and Major Businesses
Table 118. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cardinal Health SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cardinal Health Recent Developments
Table 121. Lantheus Medical Imaging Company Information
Table 122. Lantheus Medical Imaging Description and Major Businesses
Table 123. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lantheus Medical Imaging Recent Developments
Table 126. Bracco Imaging Company Information
Table 127. Bracco Imaging Description and Major Businesses
Table 128. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Bracco Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Bracco Imaging Recent Developments
Table 131. Eczacibasi-Monrol Nuclear Products Company Information
Table 132. Eczacibasi-Monrol Nuclear Products Description and Major Businesses
Table 133. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Eczacibasi-Monrol Nuclear Products Recent Developments
Table 136. IBA Molecular Imaging Company Information
Table 137. IBA Molecular Imaging Description and Major Businesses
Table 138. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. IBA Molecular Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. IBA Molecular Imaging Recent Developments
Table 141. Jubilant Life Sciences Company Information
Table 142. Jubilant Life Sciences Description and Major Businesses
Table 143. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Jubilant Life Sciences SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Jubilant Life Sciences Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. SPECT Radiopharmaceuticals Distributors List
Table 149. SPECT Radiopharmaceuticals Customers List
Table 150. SPECT Radiopharmaceuticals Market Trends
Table 151. SPECT Radiopharmaceuticals Market Drivers
Table 152. SPECT Radiopharmaceuticals Market Challenges
Table 153. SPECT Radiopharmaceuticals Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. SPECT Radiopharmaceuticals Product Picture
Figure 2. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global SPECT Radiopharmaceuticals Market Share by Type in 2023 & 2030
Figure 4. Technetium-99 Product Picture
Figure 5. Thallium-201 Product Picture
Figure 6. Gallium-67 Product Picture
Figure 7. Iodine-123 Product Picture
Figure 8. Indium-111 Product Picture
Figure 9. Other Product Picture
Figure 10. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global SPECT Radiopharmaceuticals Market Share by Application in 2023 & 2030
Figure 12. Oncology
Figure 13. Cardiology
Figure 14. Thyroid
Figure 15. SPECT Radiopharmaceuticals Report Years Considered
Figure 16. Global SPECT Radiopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global SPECT Radiopharmaceuticals Revenue 2019-2030 (US$ Million)
Figure 18. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
Figure 20. Global SPECT Radiopharmaceuticals Sales 2019-2030 ((K Units)
Figure 21. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2030)
Figure 22. US & Canada SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 23. US & Canada SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 25. Europe SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 27. China SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 29. Asia (excluding China) SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The SPECT Radiopharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of SPECT Radiopharmaceuticals in the World: Market Share by SPECT Radiopharmaceuticals Revenue in 2023
Figure 34. Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 36. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 37. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 38. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 40. US & Canada SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 42. US & Canada SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 44. US & Canada SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 45. U.S. SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 46. Canada SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 47. Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 48. Europe SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 49. Europe SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 50. Europe SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 51. Europe SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 52. Europe SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 53. Germany SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 54. France SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 56. Italy SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 57. Russia SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 58. China SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 59. China SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 60. China SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 61. China SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 62. Asia SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 63. Asia SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 64. Asia SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 65. Asia SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 66. Asia SPECT Radiopharmaceuticals Revenue Share by Region (2019-2030)
Figure 67. Asia SPECT Radiopharmaceuticals Sales Share by Region (2019-2030)
Figure 68. Japan SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 72. India SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 79. Brazil SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 82. Israel SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 84. SPECT Radiopharmaceuticals Value Chain
Figure 85. SPECT Radiopharmaceuticals Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Technetium-99
Table 3. Major Manufacturers of Thallium-201
Table 4. Major Manufacturers of Gallium-67
Table 5. Major Manufacturers of Iodine-123
Table 6. Major Manufacturers of Indium-111
Table 7. Major Manufacturers of Other
Table 8. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global SPECT Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 11. Global SPECT Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 12. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 13. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2025-2030)
Table 14. Global SPECT Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global SPECT Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 16. Global SPECT Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
Table 17. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 18. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2025-2030)
Table 19. Global SPECT Radiopharmaceuticals Sales by Manufacturers (2019-2024) & (K Units)
Table 20. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2019-2024)
Table 21. Global SPECT Radiopharmaceuticals Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 22. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 23. Global Key Players of SPECT Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
Table 24. SPECT Radiopharmaceuticals Price by Manufacturers 2019-2024 (USD/Unit)
Table 25. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT Radiopharmaceuticals as of 2023)
Table 27. Global Key Manufacturers of SPECT Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of SPECT Radiopharmaceuticals, Product Offered and Application
Table 29. Global Key Manufacturers of SPECT Radiopharmaceuticals, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 32. Global SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 33. Global SPECT Radiopharmaceuticals Sales Share by Type (2019-2024)
Table 34. Global SPECT Radiopharmaceuticals Sales Share by Type (2025-2030)
Table 35. Global SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 36. Global SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 37. Global SPECT Radiopharmaceuticals Revenue Share by Type (2019-2024)
Table 38. Global SPECT Radiopharmaceuticals Revenue Share by Type (2025-2030)
Table 39. SPECT Radiopharmaceuticals Price by Type (2019-2024) & (USD/Unit)
Table 40. Global SPECT Radiopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Unit)
Table 41. Global SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 42. Global SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 43. Global SPECT Radiopharmaceuticals Sales Share by Application (2019-2024)
Table 44. Global SPECT Radiopharmaceuticals Sales Share by Application (2025-2030)
Table 45. Global SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global SPECT Radiopharmaceuticals Revenue Share by Application (2019-2024)
Table 48. Global SPECT Radiopharmaceuticals Revenue Share by Application (2025-2030)
Table 49. SPECT Radiopharmaceuticals Price by Application (2019-2024) & (USD/Unit)
Table 50. Global SPECT Radiopharmaceuticals Price Forecast by Application (2025-2030) & (USD/Unit)
Table 51. US & Canada SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 52. US & Canada SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 53. US & Canada SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 54. US & Canada SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 55. US & Canada SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 56. US & Canada SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 57. US & Canada SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 58. US & Canada SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 59. US & Canada SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. US & Canada SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 61. US & Canada SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 62. US & Canada SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 63. US & Canada SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 64. Europe SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 65. Europe SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 66. Europe SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 69. Europe SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 70. Europe SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 76. Europe SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 77. China SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 78. China SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 79. China SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 80. China SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 81. China SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 82. China SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 83. China SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 84. China SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 85. Asia SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 86. Asia SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 87. Asia SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 88. Asia SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 89. Asia SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 90. Asia SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 91. Asia SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 92. Asia SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 93. Asia SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 94. Asia SPECT Radiopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
Table 95. Asia SPECT Radiopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
Table 96. Asia SPECT Radiopharmaceuticals Sales by Region (2019-2024) & (K Units)
Table 97. Asia SPECT Radiopharmaceuticals Sales by Region (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Type (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Type (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2019-2024) & (K Units)
Table 103. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Application (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Application (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 107. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales by Country (2025-2030) & (K Units)
Table 111. GE Healthcare Company Information
Table 112. GE Healthcare Description and Major Businesses
Table 113. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GE Healthcare SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. GE Healthcare Recent Developments
Table 116. Cardinal Health Company Information
Table 117. Cardinal Health Description and Major Businesses
Table 118. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Cardinal Health SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cardinal Health Recent Developments
Table 121. Lantheus Medical Imaging Company Information
Table 122. Lantheus Medical Imaging Description and Major Businesses
Table 123. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lantheus Medical Imaging Recent Developments
Table 126. Bracco Imaging Company Information
Table 127. Bracco Imaging Description and Major Businesses
Table 128. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Bracco Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Bracco Imaging Recent Developments
Table 131. Eczacibasi-Monrol Nuclear Products Company Information
Table 132. Eczacibasi-Monrol Nuclear Products Description and Major Businesses
Table 133. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Eczacibasi-Monrol Nuclear Products Recent Developments
Table 136. IBA Molecular Imaging Company Information
Table 137. IBA Molecular Imaging Description and Major Businesses
Table 138. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. IBA Molecular Imaging SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. IBA Molecular Imaging Recent Developments
Table 141. Jubilant Life Sciences Company Information
Table 142. Jubilant Life Sciences Description and Major Businesses
Table 143. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Jubilant Life Sciences SPECT Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Jubilant Life Sciences Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. SPECT Radiopharmaceuticals Distributors List
Table 149. SPECT Radiopharmaceuticals Customers List
Table 150. SPECT Radiopharmaceuticals Market Trends
Table 151. SPECT Radiopharmaceuticals Market Drivers
Table 152. SPECT Radiopharmaceuticals Market Challenges
Table 153. SPECT Radiopharmaceuticals Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. SPECT Radiopharmaceuticals Product Picture
Figure 2. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global SPECT Radiopharmaceuticals Market Share by Type in 2023 & 2030
Figure 4. Technetium-99 Product Picture
Figure 5. Thallium-201 Product Picture
Figure 6. Gallium-67 Product Picture
Figure 7. Iodine-123 Product Picture
Figure 8. Indium-111 Product Picture
Figure 9. Other Product Picture
Figure 10. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global SPECT Radiopharmaceuticals Market Share by Application in 2023 & 2030
Figure 12. Oncology
Figure 13. Cardiology
Figure 14. Thyroid
Figure 15. SPECT Radiopharmaceuticals Report Years Considered
Figure 16. Global SPECT Radiopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global SPECT Radiopharmaceuticals Revenue 2019-2030 (US$ Million)
Figure 18. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2019-2030)
Figure 20. Global SPECT Radiopharmaceuticals Sales 2019-2030 ((K Units)
Figure 21. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2019-2030)
Figure 22. US & Canada SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 23. US & Canada SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 25. Europe SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 27. China SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 29. Asia (excluding China) SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The SPECT Radiopharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of SPECT Radiopharmaceuticals in the World: Market Share by SPECT Radiopharmaceuticals Revenue in 2023
Figure 34. Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 36. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 37. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 38. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 40. US & Canada SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 42. US & Canada SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 44. US & Canada SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 45. U.S. SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 46. Canada SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 47. Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 48. Europe SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 49. Europe SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 50. Europe SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 51. Europe SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 52. Europe SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 53. Germany SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 54. France SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 56. Italy SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 57. Russia SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 58. China SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 59. China SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 60. China SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 61. China SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 62. Asia SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 63. Asia SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 64. Asia SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 65. Asia SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 66. Asia SPECT Radiopharmaceuticals Revenue Share by Region (2019-2030)
Figure 67. Asia SPECT Radiopharmaceuticals Sales Share by Region (2019-2030)
Figure 68. Japan SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 72. India SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America SPECT Radiopharmaceuticals Sales Share by Country (2019-2030)
Figure 79. Brazil SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 82. Israel SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries SPECT Radiopharmaceuticals Revenue (2019-2030) & (US$ Million)
Figure 84. SPECT Radiopharmaceuticals Value Chain
Figure 85. SPECT Radiopharmaceuticals Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Gadolinium DOTA Meglumine Market Research Report 2025
Apr 23, 25
Global Crisaborole API Market Research Report 2025
Apr 23, 25
Global Glyceryl Monooleate Market Research Report 2025
Apr 23, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232